CN104523576A - Polyhexamethylene guanidine cream - Google Patents

Polyhexamethylene guanidine cream Download PDF

Info

Publication number
CN104523576A
CN104523576A CN201410841827.5A CN201410841827A CN104523576A CN 104523576 A CN104523576 A CN 104523576A CN 201410841827 A CN201410841827 A CN 201410841827A CN 104523576 A CN104523576 A CN 104523576A
Authority
CN
China
Prior art keywords
cream
polyhexamethylene guanidine
mixture
guanidine
peg1500
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410841827.5A
Other languages
Chinese (zh)
Inventor
卫国刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410841827.5A priority Critical patent/CN104523576A/en
Publication of CN104523576A publication Critical patent/CN104523576A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the technical field of a skin sterilization product, in particular to a polyhexamethylene guanidine cream. The polyhexamethylene guanidine cream is composed of, by mass, 0.1%-5% of polyhexamethylen guanidine hydrochloride, 1% of a synergistic agent, 2% of azone, 0.5% of vitamin E, 45%-50% of PEG300 and 45%-50% of PEG1500. The manufacturing process includes the steps that according to the proportion, the equal amounts of PEG300 and PEG1500 are mixed and stirred for 15 minutes to obtain a cream body A; according to the proportion, the polyhexamethylen guanidine hydrochloride and the synergistic agent are mixed and stirred to obtain a mixture B; according to the proportion, the azone, the vitamin E and the mixture B are sequentially added into the cream body A and stirred for 30 minutes until the mixture is even, and the polyhexamethylene guanidine cream is obtained. The polyhexamethylene guanidine cream has the advantages that the formula is scientific and reasonable, the effect is rapid, no stimulation appears, no toxic and side effect appears, no resistance to drugs appears, and the use is convenient.

Description

Polyhexamethylene guanidine emulsifiable paste
Technical field:
The present invention relates to skin sterilization product technical field, be specifically related to a kind of polyhexamethylene guanidine emulsifiable paste.
Background technology:
Environment-friendly type macromolecule polymer bactericide---polyhexamethylene guanidine, has broad-spectrum; Valid density is low; Speed of action is fast; Stable in properties; Premium properties soluble in water; Can use at normal temperatures; For a long time antibacterial, have no side effect; Non-corrosiveness; Colourless, odorless; Nontoxic; Do not fire, not quick-fried, use safety; Convenient transportation, can be described as best antibacterial.In fact, this product is a kind of environment-friendly multipurpose new polymers, in industrial, agriculture, medical and daily life, have purposes extremely widely.
Polyhexamethylene guanidine is used for dermatosis: the killing action of this product to antibacterial, fungus is strong, effect is lasting, therefore can easily for the various dermatosiss caused by the sex pheromones such as dermatophytosis, yeast, mycete, staphylococcus aureus, Candida albicans, escherichia coli, pathogenic bacterium.And play antipruritic, putrefaction-removing granulation-promoting, recovery skin normal function effect.
But when polyhexamethylene guanidine is applied to skin surface at present, be the form adopting liquid fungicide mostly, use inconvenience, effect is bad.
Summary of the invention:
The object of this invention is to provide a kind of polyhexamethylene guanidine emulsifiable paste, its scientific formulation is reasonable, have rapid-action, do not stimulate, have no side effect, without Drug resistance, the feature such as easy to use.
In order to solve the problem existing for background technology, the present invention is by the following technical solutions: its quality consists of than formula: Polyhaxemethylenguanidine Hydrochloride 0.1%-5%, synergist 1%, azone 2%, vitamin E 0.5%, PEG300 45%-50%, PEG1500 45%-50%.
Production technology of the present invention is:
(1). according to aforementioned proportion, PEG300 and PEG1500 of equivalent mixed and stirs 15 minutes, obtaining body of paste A;
(2). according to aforementioned proportion, Polyhaxemethylenguanidine Hydrochloride and synergist mixed and stirs, obtaining mixture B;
(3). azone, vitamin E and mixture B are added in body of paste A according to aforementioned proportion successively, stirs 30 minutes until mix homogeneously, obtain polyhexamethylene guanidine emulsifiable paste.
Polyhexamethylene guanidine emulsifiable paste of the present invention is applicable to the various dermatosiss caused by the sex pheromones such as dermatophytosis, yeast, mycete, staphylococcus aureus, Candida albicans, escherichia coli, pathogenic bacterium, the scytitis caused as contact dermatitis, neurodermatitis, seborrheic dermatitis, folliculitis, eczema, psoriasis, lichen planus, chronicus, pompholyx disease etc. and the treatment of skin pruritus.
The present invention has following beneficial effect:
1. rapid-action: dermal application administration, sterilization rapidly, successful.
2. do not stimulate: multinomial toxicology shows, skin, wound are not stimulated.
3. have no side effect: multinomial pharmacology shows, has no side effect, safe and reliable.
4. without Drug resistance: unique pathogenic bacteria principle of killing makes it without Drug resistance, and permanence operation does not subtract.
5. easy to use: medicine is directly coated onto affected part, use whenever and wherever possible.
Detailed description of the invention:
In order to make object of the present invention, technical scheme and advantage clearly understand, below in conjunction with detailed description of the invention, the present invention is further elaborated.Should be appreciated that detailed description of the invention described herein only in order to explain the present invention, be not intended to limit the present invention.
This detailed description of the invention is by the following technical solutions: its quality consists of than formula: Polyhaxemethylenguanidine Hydrochloride 0.1%-5%, synergist 1%, azone 2%, vitamin E 0.5%, PEG30045%-50%, PEG1500 45%-50%.
The production technology of this detailed description of the invention is:
(1). according to aforementioned proportion, PEG300 and PEG1500 of equivalent mixed and stirs 15 minutes, obtaining body of paste A;
(2). according to aforementioned proportion, Polyhaxemethylenguanidine Hydrochloride and synergist mixed and stirs, obtaining mixture B;
(3). azone, vitamin E and mixture B are added in body of paste A according to aforementioned proportion successively, stirs 30 minutes until mix homogeneously, obtain polyhexamethylene guanidine emulsifiable paste.
Usage and the consumption of this detailed description of the invention are as follows:
External, gets this product and smears skin discomfort place in right amount, every day 2-3 time, long-term chronic or situation comparatively severe one, every day 3-4 time.Use 7 days should be continued, in case recurrence after transference cure.
The pharmacological toxicology of this detailed description of the invention:
Pharmacological action
Main Ingredients and Appearance is polyhexamethylene guanidine, has broad-spectrum bactericidal action to Grain-positive, gram-negative bacteria.To pathogenic bacterium such as comprising dermatophytosis, yeast, mycete, staphylococcus aureus, Candida albicans, escherichia coli, there is bactericidal action.Its mechanism of action is that active ingredient becomes electropositive, be easy to by electronegative each bacterioid, fungus, virus adsorb and be wound around, thus suppress the splitting function of pathogenic bacteria, make antibacterial lose fertility, add the respiration channel plugging microorganism, microorganism is choked to death rapidly
Toxicological effect
Transdermal stimulation test, Eye irritation, repeatedly intact skin stimulate and a damaged skin experiment, belong to nonirritant; All belong to nontoxic through acute oral toxicity, acute inhalation toxicity, subacute toxicity test, micronucleus test.
The above is only in order to illustrate technical scheme of the present invention and unrestricted, other amendment that those of ordinary skill in the art make technical scheme of the present invention or equivalently to replace, only otherwise depart from the spirit and scope of technical solution of the present invention, all should be encompassed in the middle of right of the present invention.

Claims (1)

1. polyhexamethylene guanidine emulsifiable paste, is characterized in that its quality consists of than formula: Polyhaxemethylenguanidine Hydrochloride 0.1%-5%, synergist 1%, azone 2%, vitamin E 0.5%, PEG30045%-50%, PEG1500 45%-50%.
Polyhexamethylene guanidine emulsifiable paste, is characterized in that its production technology is:
(1). according to aforementioned proportion, PEG300 and PEG1500 of equivalent mixed and stirs 15 minutes, obtaining body of paste A;
(2). according to aforementioned proportion, Polyhaxemethylenguanidine Hydrochloride and synergist mixed and stirs, obtaining mixture B;
(3). azone, vitamin E and mixture B are added in body of paste A according to aforementioned proportion successively, stirs 30 minutes until mix homogeneously, obtain polyhexamethylene guanidine emulsifiable paste.
CN201410841827.5A 2014-12-31 2014-12-31 Polyhexamethylene guanidine cream Pending CN104523576A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410841827.5A CN104523576A (en) 2014-12-31 2014-12-31 Polyhexamethylene guanidine cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410841827.5A CN104523576A (en) 2014-12-31 2014-12-31 Polyhexamethylene guanidine cream

Publications (1)

Publication Number Publication Date
CN104523576A true CN104523576A (en) 2015-04-22

Family

ID=52839339

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410841827.5A Pending CN104523576A (en) 2014-12-31 2014-12-31 Polyhexamethylene guanidine cream

Country Status (1)

Country Link
CN (1) CN104523576A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213312A (en) * 2015-10-30 2016-01-06 卫国刚 Polyhexamethylene guanidine propionate cream for treating dexmatosis and spray
CN105535015A (en) * 2016-01-05 2016-05-04 山西海博贝马生物科技有限公司 Polyhexamethylen guanidine hydrochloride itching-relieving water spray and preparation method thereof
CN108096368A (en) * 2018-01-09 2018-06-01 江苏曦肤康生物制药有限公司 A kind of antibacterial cream of skin for treating recalcitrant dermal disease and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101628035A (en) * 2008-07-14 2010-01-20 烟台绿叶动物保健品有限公司 Suppository for treating livestock endometritis
CN103705535A (en) * 2013-12-27 2014-04-09 王东宇 Gynecological chitosan gel and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101628035A (en) * 2008-07-14 2010-01-20 烟台绿叶动物保健品有限公司 Suppository for treating livestock endometritis
CN103705535A (en) * 2013-12-27 2014-04-09 王东宇 Gynecological chitosan gel and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
常忆凌: "《药剂学》", 28 February 2009 *
张炳盛等: "《中药药剂学》", 28 February 2013 *
韩丽等: "《药剂学实验》", 31 August 2014 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213312A (en) * 2015-10-30 2016-01-06 卫国刚 Polyhexamethylene guanidine propionate cream for treating dexmatosis and spray
CN105535015A (en) * 2016-01-05 2016-05-04 山西海博贝马生物科技有限公司 Polyhexamethylen guanidine hydrochloride itching-relieving water spray and preparation method thereof
CN108096368A (en) * 2018-01-09 2018-06-01 江苏曦肤康生物制药有限公司 A kind of antibacterial cream of skin for treating recalcitrant dermal disease and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105055304A (en) Leave-on skin care and disinfection gel containing composite sterilization component, and preparation method thereof
CN104523576A (en) Polyhexamethylene guanidine cream
WO2016026600A1 (en) Cineole-containing composition for nasal application
CN112022732A (en) Hand-washing-free disinfectant and preparation method thereof
EP2648704B1 (en) Anti-microbial composition
CN106176603B (en) A kind of plants essential oil micro emulsion gel and its preparation method and application
CN105010358A (en) Bactericidal composition and application thereof
CN111588723B (en) Gynecological disinfectant and preparation method thereof
CN107412213B (en) Multifunctional external antibacterial and sterilizing agent and preparation method thereof
CN109432201B (en) Gynecological antibacterial gel and preparation method thereof
CN100396290C (en) External use anti-bacteria foaming agent for gynecology
CN103110572B (en) Gynecological antimicrobial gel recipe and preparation method thereof
CN104398534A (en) Polyhexamethylene guanidine eye drops
CN104586767A (en) Polyhexamethylene guanidine oral spray
CN107018999A (en) A kind of mobile phone disinfection hygenic towelette gently stablized and its application
CN102697786A (en) Urotropine composite skin disinfectant and preparation method thereof
CN104147603A (en) Application of novel marine algae extractive composition in preventing virus flu
CN102846489B (en) Polyhexamethyleneguanidine hydrochloride iodine medicine bath liquid and preparation method thereof
CN104288773A (en) Preparation method of external sulfanilamide drug, external sulfanilamide drug and application of external sulfanilamide drug
CN106692185A (en) Preparation method of medical disinfectant
AU2020201113A1 (en) Antimicrobial compositions and methods of use
CN105560166A (en) Gynecological external antibacterial gel with silver ions and method for preparing gynecological external antibacterial gel
RU2706115C1 (en) Antifungal and antimicrobial agent of complex action
CN105030894A (en) Iodophor disinfection paste and preparation method thereof
CN105213312A (en) Polyhexamethylene guanidine propionate cream for treating dexmatosis and spray

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150422

RJ01 Rejection of invention patent application after publication